
Juvena W. Loo
Examiner (ID: 18974, Phone: (571)270-1974 , Office: P/2473 )
| Most Active Art Unit | 2473 |
| Art Unit(s) | 2473, 2616, 2416, 2609 |
| Total Applications | 547 |
| Issued Applications | 438 |
| Pending Applications | 1 |
| Abandoned Applications | 108 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14196393
[patent_doc_number] => 10265282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-23
[patent_title] => Cancer treatment
[patent_app_type] => utility
[patent_app_number] => 15/980644
[patent_app_country] => US
[patent_app_date] => 2018-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1645
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15980644
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/980644 | Cancer treatment | May 14, 2018 | Issued |
Array
(
[id] => 13982359
[patent_doc_number] => 20190060337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => COMPOSITIONS COMPRISING BETA-GLUCOGALLIN AND THERAPEUTIC APPLICATIONS THEREOF IN CONTROLLED KINETICS OF CARBOHYDRATE BREAKDOWN AND MONOSACCHARIDE ABSORPTION
[patent_app_type] => utility
[patent_app_number] => 15/971069
[patent_app_country] => US
[patent_app_date] => 2018-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15971069
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/971069 | COMPOSITIONS COMPRISING BETA-GLUCOGALLIN AND THERAPEUTIC APPLICATIONS THEREOF IN CONTROLLED KINETICS OF CARBOHYDRATE BREAKDOWN AND MONOSACCHARIDE ABSORPTION | May 3, 2018 | Abandoned |
Array
(
[id] => 15960459
[patent_doc_number] => 20200163981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => SYNERGISTIC PRODUCTION OF BUTYRATE ASSOCIATED WITH THE COMPLEXITY OF HMOS BLEND FOR USE IN INFANTS OR YOUNG CHILDREN FOR HEALTH PURPOSES
[patent_app_type] => utility
[patent_app_number] => 16/611282
[patent_app_country] => US
[patent_app_date] => 2018-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12050
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611282
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/611282 | Synergistic production of butyrate associated with the complexity of HMOS blend for use in infants or young children for health purposes | May 3, 2018 | Issued |
Array
(
[id] => 18273694
[patent_doc_number] => 11612615
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-28
[patent_title] => Combined administration of cysteine-aspartic protease inhibitors with P2Y12 receptor antagonists protects the heart against myocardial infarction
[patent_app_type] => utility
[patent_app_number] => 16/608262
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7129
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608262
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608262 | Combined administration of cysteine-aspartic protease inhibitors with P2Y12 receptor antagonists protects the heart against myocardial infarction | Apr 26, 2018 | Issued |
Array
(
[id] => 13410143
[patent_doc_number] => 20180256614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => COMPOSITIONS AND METHODS OF TREATING OF BACTERIAL INFECTIONS WITH BETA-LACTAMASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/961738
[patent_app_country] => US
[patent_app_date] => 2018-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15961738
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/961738 | Compositions and methods of treating of bacterial infections with b-lactamase inhibitors | Apr 23, 2018 | Issued |
Array
(
[id] => 17052148
[patent_doc_number] => 20210261582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => AZITHROMYCIN DERIVATIVES CONTAINING A PHOSPHONIUM ION AS ANTICANCER AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/606336
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 422
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606336
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606336 | Azithromycin derivatives containing a phosphonium ion as anticancer agents | Apr 19, 2018 | Issued |
Array
(
[id] => 15586351
[patent_doc_number] => 20200069710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => COMPOSITIONS FOR TREATMENT OF HYPERGLYCEMIA IN DIABETES MELLITUS PATIENTS
[patent_app_type] => utility
[patent_app_number] => 16/605826
[patent_app_country] => US
[patent_app_date] => 2018-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16605826
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/605826 | COMPOSITIONS FOR TREATMENT OF HYPERGLYCEMIA IN DIABETES MELLITUS PATIENTS | Apr 17, 2018 | Abandoned |
Array
(
[id] => 18444634
[patent_doc_number] => 11680194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-20
[patent_title] => Method for producing silicone-based adhesive
[patent_app_type] => utility
[patent_app_number] => 16/606556
[patent_app_country] => US
[patent_app_date] => 2018-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 4
[patent_no_of_words] => 8655
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 273
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606556
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606556 | Method for producing silicone-based adhesive | Apr 12, 2018 | Issued |
Array
(
[id] => 13364281
[patent_doc_number] => 20180233680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => PLATINUM(II) COMPLEXES FOR OLED APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 15/950650
[patent_app_country] => US
[patent_app_date] => 2018-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15950650
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/950650 | Platinum(II) complexes for OLED applications | Apr 10, 2018 | Issued |
Array
(
[id] => 17821497
[patent_doc_number] => 11426420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Inhibitors of short-chain dehydrogenase activity for treating coronary disorders
[patent_app_type] => utility
[patent_app_number] => 16/603544
[patent_app_country] => US
[patent_app_date] => 2018-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21212
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 392
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603544
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603544 | Inhibitors of short-chain dehydrogenase activity for treating coronary disorders | Apr 8, 2018 | Issued |
Array
(
[id] => 17665349
[patent_doc_number] => 11359030
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Method for preparing low molecular weight hyaluronic acid
[patent_app_type] => utility
[patent_app_number] => 16/495617
[patent_app_country] => US
[patent_app_date] => 2018-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5139
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16495617
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/495617 | Method for preparing low molecular weight hyaluronic acid | Apr 8, 2018 | Issued |
Array
(
[id] => 15738373
[patent_doc_number] => 20200108074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => COMBINATIONS OF CHK1- AND WEE1- INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/498351
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16294
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498351
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/498351 | COMBINATIONS OF CHK1- AND WEE1- INHIBITORS | Mar 29, 2018 | Abandoned |
Array
(
[id] => 15527369
[patent_doc_number] => 20200055990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => (METH)ACRYLIC-MODIFIED SILOXANE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/498989
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3430
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498989
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/498989 | (Meth)acrylic-modified siloxane compound | Mar 28, 2018 | Issued |
Array
(
[id] => 17742637
[patent_doc_number] => 11390694
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Gellan gum with double setting temperatures and the preparation method and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/495345
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4329
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16495345
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/495345 | Gellan gum with double setting temperatures and the preparation method and use thereof | Mar 28, 2018 | Issued |
Array
(
[id] => 16009183
[patent_doc_number] => 20200179434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => CRANBERRY-DERIVED COMPOSITIONS FOR POTENTIATING ANTIBIOTIC EFFICACY AGAINST BACTERIAL PERSISTENCE
[patent_app_type] => utility
[patent_app_number] => 16/498359
[patent_app_country] => US
[patent_app_date] => 2018-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498359
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/498359 | Cranberry-derived compositions for potentiating antibiotic efficacy against bacterial persistence | Mar 26, 2018 | Issued |
Array
(
[id] => 13207007
[patent_doc_number] => 10117854
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-06
[patent_title] => Method for treating hepatic encephalopathy
[patent_app_type] => utility
[patent_app_number] => 15/935695
[patent_app_country] => US
[patent_app_date] => 2018-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 42
[patent_no_of_words] => 6170
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15935695
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/935695 | Method for treating hepatic encephalopathy | Mar 25, 2018 | Issued |
Array
(
[id] => 15800077
[patent_doc_number] => 20200123181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => METHOD FOR PREPARING ARYLALKOXYSILANES BY DEHYDROGENATIVE SILYLATION
[patent_app_type] => utility
[patent_app_number] => 16/604374
[patent_app_country] => US
[patent_app_date] => 2018-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604374
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604374 | METHOD FOR PREPARING ARYLALKOXYSILANES BY DEHYDROGENATIVE SILYLATION | Mar 22, 2018 | Abandoned |
Array
(
[id] => 13328467
[patent_doc_number] => 20180215771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => TUNABLE RARE-EARTH FCU-METAL-ORGANIC FRAMEWORKS
[patent_app_type] => utility
[patent_app_number] => 15/926511
[patent_app_country] => US
[patent_app_date] => 2018-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15926511
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/926511 | Tunable rare-earth fcu-metal-organic frameworks | Mar 19, 2018 | Issued |
Array
(
[id] => 16946651
[patent_doc_number] => 20210205342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => NICOTINAMIDE RIBOSIDE FOR USE IN TREATING OR PREVENTING LIVER DAMAGE
[patent_app_type] => utility
[patent_app_number] => 16/494581
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494581
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494581 | Nicotinamide riboside for use in treating or preventing liver damage | Mar 15, 2018 | Issued |
Array
(
[id] => 13300857
[patent_doc_number] => 20180201965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => METHOD FOR PRODUCING GALACTOOLIGOSACCHARIDES FROM LACTOSE
[patent_app_type] => utility
[patent_app_number] => 15/923957
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15923957
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/923957 | Method for producing galactooligosaccharides from lactose | Mar 15, 2018 | Issued |